Journal: Heart, Lung & Circulation

Article Title: Acute Myocarditis and Pericarditis After m-RNA COVID-19 Vaccinations—A Single-Centre Retrospective Analysis

doi: 10.1016/j.hlc.2023.01.002

Figure Lengend Snippet: Electrocardiogram (ECG) for Case 8 on presentation post Pfizer COVID-19 vaccination showing diffuse ST segment elevation and PR segment depression in leads II, III, aVF; in addition to Spodick’s sign (downsloping TP segment) in leads II, III and V3-V6.

Article Snippet: Each patient’s medical record was reviewed for administration of COVID-19 Pfizer-BioNTech, Astra-Zeneca, and Moderna vaccines prior to presentation.

Techniques:

Journal: Clinical Imaging

Article Title: Unilateral axillary Adenopathy in the setting of COVID-19 vaccine

doi: 10.1016/j.clinimag.2021.01.016

Figure Lengend Snippet: 59-year-old female with palpable unilateral left axillary adenopathy noted approximately 9 days after receiving the first dose of the Pfizer-BioNTech Covid-19 vaccine in her left upper extremity. (a) Gray-scale and (b) color Doppler images of an enlarged left axillary lymph node measuring 2.6 × 1.5 × 1.6 cm with uniform cortical thickening up to 0.7 cm (arrow). Normal right axillary lymph node (arrowhead) was noted.

Article Snippet: Per electronic medical record, patient received the second dose of the Pfizer-BioNTech COVID-19 vaccine in her left upper extremity 5 days prior.

Techniques:

Journal: Clinical Imaging

Article Title: Unilateral axillary Adenopathy in the setting of COVID-19 vaccine

doi: 10.1016/j.clinimag.2021.01.016

Figure Lengend Snippet: 42-year-old female with unilateral left axillary adenopathy noted 5 days after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine in her left upper extremity. (a) Gray-scale and (b) color Doppler images of an enlarged left axillary lymph node with cortical thickening (arrow). (c) Multiple additional morphologically abnormal left axillary lymph nodes were also present (arrows). Unremarkable right axilla was documented (d).

Article Snippet: Per electronic medical record, patient received the second dose of the Pfizer-BioNTech COVID-19 vaccine in her left upper extremity 5 days prior.

Techniques:

Journal: Clinical Imaging

Article Title: Unilateral axillary Adenopathy in the setting of COVID-19 vaccine

doi: 10.1016/j.clinimag.2021.01.016

Figure Lengend Snippet: 42-year-old female with unilateral left axillary adenopathy noted 13 days after receiving the first dose of the Moderna COVID-19 vaccine in her left upper extremity. (a) Gray-scale and (b) color Doppler images of an enlarged left axillary lymph node with diffuse cortical thickening (arrows). Unremarkable right axilla was documented (c).

Article Snippet: Per electronic medical record, patient received the second dose of the Pfizer-BioNTech COVID-19 vaccine in her left upper extremity 5 days prior.

Techniques:

Journal: Clinical Imaging

Article Title: Unilateral axillary Adenopathy in the setting of COVID-19 vaccine

doi: 10.1016/j.clinimag.2021.01.016

Figure Lengend Snippet: 57-year-old female with unilateral left axillary adenopathy noted 8 days after receiving the first dose of the Pfizer-BioNTech Covid-19 vaccine in her left upper extremity. (a) Gray-scale and (b) color Doppler images of a single enlarged left axillary lymph node with diffuse cortical thickening. Unremarkable right axilla was documented (c).

Article Snippet: Per electronic medical record, patient received the second dose of the Pfizer-BioNTech COVID-19 vaccine in her left upper extremity 5 days prior.

Techniques: